Earli
Robby Chandra has worked as a Library Student Assistant at the University of San Francisco since 2018, and also held a Research Intern position at the University of California, San Francisco in the same year. In 2020, they began working as a Research Associate II at Charles River Laboratories, and is currently a Senior Research Associate at Earli Inc. since 2022.
Robby Chandra attended the University of San Francisco from 2016 to 2020, where they earned a degree in Environmental Science with a focus in Pre-Medicine/Pre-Medical Studies. In 2015, they obtained a certification from Comcast as part of their Digital Connectors program. In 2022, they began pursuing a Master of Science in Healthcare Analytics at the University of San Diego, which they expect to complete in 2023.
This person is not in any offices
Earli
1 followers
Earli has an ambitious mission: to force cancer reveal its location at its earliest stages, which makes it quickly treatable. In other words, they aim to make cancer a benign experience. Their science is based on a new method of detecting, localizing and then treating cancer called "Synthetic Biopsies," originally developed by the late Dr. Sam Gambhir at Stanford.